Atomic-Resolution Structure of a Class C β-Lactamase and Its Complex with Avibactam

Probing the Mechanism of Inactivation of the FOX-4 Cephamycinase by Avibactam

(2018) Michiyoshi Nukaga et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New β-Lactamase Inhibitors in the Clinic

(2016) Krisztina M. Papp-Wallace et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Analysis of the Structure and Function of FOX-4 Cephamycinase

(2015) S. T. Lefurgy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Crystal Structure of Mox-1, a Unique Plasmid-Mediated Class C β-Lactamase with Hydrolytic Activity towards Moxalactam

(2014) Takuma Oguri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Avibactam and Class C β-Lactamases: Mechanism of Inhibition, Conservation of the Binding Pocket, and Implications for Resistance

(2014) S. D. Lahiri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)

(2014) R. K. Flamm et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases

(2013) Sushmita D. Lahiri et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase

(2013) Sandrine Dahyot et al.   FEMS MICROBIOLOGY LETTERS

Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases

(2013) David E. Ehmann et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

NXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosis

(2012) Hua Xu et al.   BIOCHEMISTRY

Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study

(2012) José A. Vazquez et al.   CURRENT MEDICAL RESEARCH AND OPINION

Avibactam is a covalent, reversible, non- -lactam  -lactamase inhibitor

(2012) D. E. Ehmann et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Precession electron diffraction of Mn2O3and PbMnO2.75: solving structures where X-rays fail

(2011) Holger Klein   ACTA CRYSTALLOGRAPHICA SECTION A

Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria

(2010) Karen Bush et al.   Annual Review of Microbiology

Genetic and Biochemical Characterization of TRU-1, the Endogenous Class C  -Lactamase from Aeromonas enteropelogenes

(2010) F. De Luca et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Three Decades of  -Lactamase Inhibitors

(2010) S. M. Drawz et al.   CLINICAL MICROBIOLOGY REVIEWS

Current Challenges in Antimicrobial Chemotherapy

(2010) Carine Bebrone et al.   DRUGS

The long-wavelength limit of the structure factor of amorphous silicon and vitreous silica

(2009) Adam M. R. de Graff et al.   ACTA CRYSTALLOGRAPHICA SECTION A

AmpC  -Lactamases

(2009) G. A. Jacoby   CLINICAL MICROBIOLOGY REVIEWS

Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7

(2008) Gerrit Langer et al.   Nature Protocols